Amgen (AMGN) Total Liabilities (2009 - 2026)

Amgen has reported Total Liabilities for 18 years, with the latest figure at $84.0 billion in Q2 2026.

• On a quarterly basis, Total Liabilities rose 4.33% year-over-year to $84.0 billion in Q2 2026; TTM through Jun 2026 was $84.0 billion, a 4.33% increase from a year earlier, with the FY2025 full-year figure at $81.9 billion, down 4.69% from the prior year.
• Total Liabilities was $84.0 billion for Q2 2026 at Amgen, up from $83.3 billion in the prior quarter.
• The five-year high for Total Liabilities was $90.9 billion in Q4 2023, with the low at $56.9 billion in Q2 2022.
• Average Total Liabilities over 5 years is $78.5 billion, with a median of $83.2 billion recorded in 2025.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities jumped 47.94% in 2023, then retreated 5.46% in 2024.
• Over 5 years, Total Liabilities stood at $61.5 billion in 2022, then surged by 47.94% to $90.9 billion in 2023, then slipped by 5.46% to $86.0 billion in 2024, then dropped by 4.69% to $81.9 billion in 2025, then rose by 2.47% to $84.0 billion in 2026.
• The last three Total Liabilities figures came in at $84.0 billion (Q2 2026), $83.3 billion (Q1 2026), and $81.9 billion (Q4 2025), per Business Quant data.